Compare AZTA & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AZTA | IRMD |
|---|---|---|
| Founded | 1978 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 1996 | 2014 |
| Metric | AZTA | IRMD |
|---|---|---|
| Price | $26.31 | $97.13 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | $40.60 | ★ $116.00 |
| AVG Volume (30 Days) | ★ 638.5K | 123.9K |
| Earning Date | 05-06-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 0.95% |
| EPS Growth | ★ 60.52 | 16.67 |
| EPS | N/A | ★ 0.45 |
| Revenue | ★ $593,821,000.00 | $83,814,000.00 |
| Revenue This Year | $6.99 | $12.38 |
| Revenue Next Year | $5.98 | $11.31 |
| P/E Ratio | ★ N/A | $216.44 |
| Revenue Growth | N/A | ★ 14.43 |
| 52 Week Low | $15.93 | $55.11 |
| 52 Week High | $41.73 | $107.90 |
| Indicator | AZTA | IRMD |
|---|---|---|
| Relative Strength Index (RSI) | 61.32 | 53.67 |
| Support Level | $24.25 | $96.43 |
| Resistance Level | $27.37 | $97.63 |
| Average True Range (ATR) | 1.10 | 3.75 |
| MACD | 0.03 | -0.30 |
| Stochastic Oscillator | 73.44 | 51.81 |
Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.
iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.